|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12N 9/64 |
| (11) | Number of the document | 2281037 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09730852.2 |
| Date of filing the European patent application | 2009-04-10 | |
| (97) | Date of publication of the European application | 2011-02-09 |
| (45) | Date of publication and mention of the grant of the patent | 2015-11-11 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/002248 |
| Date | 2009-04-10 |
| (87) | Number | WO 2009/126307 |
| Date | 2009-10-15 |
| (30) | Number | Date | Country code |
| 124021 P | 2008-04-11 | US |
| (72) |
MADISON, Edwin, L., US
THANOS, Christopher, US
|
| (73) |
Catalyst Biosciences, Inc.,
260 Littlefield Avenue, South San Francisco, CA 94080,
US
|
| (54) | FACTOR VII POLYPEPTIDES THAT ARE MODIFIED AND USES THEREOF |
| FACTOR VII POLYPEPTIDES THAT ARE MODIFIED AND USES THEREOF |